A decision tool to inform the optimal use of non-pharmaceutical interventions during the COVID-19 pandemic
A decision tool to inform the optimal use of non-pharmaceutical interventions during the COVID-19 pandemic
批准号:
10738630
负责人:
Reza YAESOUBI
金额:
$22.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-25 至 2025-06-30
关键词:
2019-nCoVAddressAffectBenchmarkingCOVID-19COVID-19 pandemicCOVID-19 testCessation of lifeClinicalCommunicable DiseasesCommunicationConsumptionCost Effectiveness AnalysisDataDecision ModelingEconomicsEducationEffectivenessEpidemiologyExposure toFatigueFutureGeographyHealthHealth Care VisitHealth InsuranceHospitalizationImmune responseImmunizationInfluenzaInfluenza A Virus, H1N1 SubtypeInterruptionInterventionLiftingMasksMeasuresMental HealthMethodsMissionModelingMorbidity - disease rateOutcomePersonsPlayPoliciesPolicy MakerPoliticsPopulationPublic HealthQuality-Adjusted Life YearsQuarantineRecommendationRelaxationResearchRoleSARS-CoV-2 exposureSARS-CoV-2 positiveSARS-CoV-2 transmissionSamplingScheduleSchoolsSocial DistanceSocietiesSourceSpecific qualifier valueStructureSubstance Use DisorderTarget PopulationsTimeUnited StatesUnited States National Institutes of HealthVaccinesVariantVirusWeightadverse outcomeanalytical toolcostdesigneconomic disparityepidemic responseepidemiologic dataevidence baseexperienceexperimental studyhealth disparityimprovedincome insuranceinnovationintervention costmarginalizationmembermortalitynovelpandemic diseasepandemic influenzapandemic responsepathogen exposurepopulation healthpredictive modelingprevious pandemicprogramsschool closureseasonal influenzasocialsociodemographicstoolvaccine-induced immunity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
As the prospect for the elimination of COVID-19 in the near future remains uncertain, non-pharmaceutical
interventions (NPIs) such as limiting social gatherings, quarantine after exposure to the virus, and school
closure, will continue to play important roles in mitigating the morbidity and mortality associated with the
pandemic. Since these interventions impose immense economic, social, and health-related costs, their use
should be recommended only when epidemic control benefits outweigh their adverse consequences. Our
overall objective in this proposal is to develop an analytical decision tool to optimize the use of NPIs based on
latest information related to the local epidemiology of COVID-19, the effectiveness of different NPIs, and the
population’s stated disutility associated with these interventions. This decision tool is structured to provide a
transparent mechanism to communicate the rationale for the current policy regarding the use of NPIs and the
conditions under which the policy would change. To develop our decision tools, this proposal has three specific
aims: 1) to develop state-level decision models that identify the optimal combination of NPIs, in real-time, and
based on the projected loss in the quality-adjusted life-years (QALYs) and the disutility borne by the population
under various combinations of NPIs under various combinations of NPIs; 2) to design, conduct, and analyze
discrete-choice experiments to estimate the disutility weights of different NPIs as borne by population members
due to social, economic, and health consequences of these programs; and 3) to estimate the societal tolerance
for loss in QALYs due to existing infectious diseases without triggering NPIs. This tolerance threshold can be
estimated using historical data related to past pandemic and seasonal influenza and will serve as a benchmark
to decide when the burden of COVID-19 is low enough to lift all NPIs, at least for a short term. The research
proposed in this project is innovative as it develops a novel, principled approach to consolidate real-time data
from three different sources to optimize the use of NPIs: 1) COVID-19 cases, hospitalizations, and deaths as
projected by existing and new predictive models of COVID-19 pandemic, 2) effectiveness of various NPIs in
breaking the transmission of SARS-CoV-2, and 3) disutility weights of NPIs directly elicited from target
populations. The proposed research is significant because it meets the critical needs of policymakers to
identify evidence-based and real-time recommendations regarding the efficient use of NPIs to contain the
burden of COVID-19. The methods and decision tools developed as part of this project could also be used in
responding to other existing and future infectious threats where NPIs are employed.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancing surveillance systems to slow the spread of antimicrobial-resistant gonorrhea in the United States
-
批准号:10623254
-
项目类别:
-
资助金额:$41.67万
-
财政年份:2020
-
负责人:Reza YAESOUBI
-
依托单位:
Enhancing surveillance systems to slow the spread of antimicrobial-resistant gonorrhea in the United States
-
批准号:10031094
-
项目类别:
-
资助金额:$46.0万
-
财政年份:2020
-
负责人:Reza YAESOUBI
-
依托单位:
Enhancing surveillance systems to slow the spread of antimicrobial-resistant gonorrhea in the United States
-
批准号:10200650
-
项目类别:
-
资助金额:$41.67万
-
财政年份:2020
-
负责人:Reza YAESOUBI
-
依托单位:
Enhancing surveillance systems to slow the spread of antimicrobial-resistant gonorrhea in the United States
-
批准号:10415148
-
项目类别:
-
资助金额:$41.67万
-
财政年份:2020
-
负责人:Reza YAESOUBI
-
依托单位:
Improving the control of multidrug-resistant tuberculosis through targeted screening and use of novel anti-tuberculosis drugs
-
批准号:9109823
-
项目类别:
-
资助金额:$13.1万
-
财政年份:2016
-
负责人:Reza YAESOUBI
-
依托单位:
Improving the control of multidrug-resistant tuberculosis through targeted screening and use of novel anti-tuberculosis drugs
-
批准号:9261472
-
项目类别:
-
资助金额:$12.94万
-
财政年份:2016
-
负责人:Reza YAESOUBI
-
依托单位:
海外基金